Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 12:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 28 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Near Infrared Camera Clear all

Conditions: Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple
Interventions: ICG Intervention, Near Infrared Camera; Drug · Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cholelithiasis, Cholecystitis, Pancreatitis Biliary, Colic of Gallbladder Without Mention of Cholecystitis
Interventions: Indocyanine Green (ICG); Drug
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Systemic Scleroderma
Interventions: Spatial-frequency domain imaging (SFDI); Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Invasive Breast Cancer
Interventions: Smart Goggle, Cardio-Green, SPY Elite Imaging system, Quest near-infrared (NIR) Imaging system, PDE Imaging system, Gamma probe, Blue Dyes; Device · Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Malignant Brain Neoplasm, Malignant Glioma
Interventions: Near-Infrared Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800, POINPOINT-IR9000; Procedure · Biological · Drug + 1 more
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: PIV Catheter Insertion, Vein Visualization
Interventions: Unassisted vein visualization, Wee Sight® Transilluminator, VeinViewer® (Christie Digital Systems, Cypress, CA); Procedure
Lead sponsor: University of Nebraska; Other
Eligibility: Up to 12 Months
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Acute Cholecystitis, Acute Cholangitis
Interventions: Indocyanine Green (ICG), Near Infrared Fluorescence Cholangiography (NIRF-C); Drug · Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Lung Neoplasms, Lung Cancer
Interventions: OTL38 for Injection, Near infrared camera imaging system; Drug · Device
Lead sponsor: On Target Laboratories, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 12
States / cities: Stamford, Connecticut • Iowa City, Iowa • Boston, Massachusetts + 8 more

Conditions: Kyphosis, Vertebral Fracture
Interventions: Near-infrared passive motion capture recording; Procedure
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Esophageal Cancer
Interventions: Injection of indocyanine green (ICG)dye, Near-Infrared Image-Guided, Sentinel Lymph Node (SLN) mapping; Other · Device · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Wound Healing, Lower Extremity Amputation, Above Knee Amputation, Below Knee Amputation
Interventions: Lower Extremity Amputation, SPY Elite Imaging System, Indocyaine Green; Procedure · Device · Drug
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Melanoma
Interventions: Indocyanine Green (IC-Green), Imaging; Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Lung Neoplasms, Lung Cancer
Interventions: OTL38 for Injection, Near infrared camera imaging system, Endoscopic or Thoracic Surgery; Drug · Device · Procedure
Lead sponsor: On Target Laboratories, LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 5
States / cities: Boston, Massachusetts • Cleveland, Ohio • Philadelphia, Pennsylvania + 2 more

Conditions: Endometrial Cancer, Near Infrared Fluorescence Imaging, CYTALUX (Pafolacianine) Injection, Planned Diagnostic Laparoscopies
Interventions: CYTALUX™ (pafolacianine), 1788 4K Camera System with Advanced Imaging Modality; Drug · Device
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Blindness, Acquired
Interventions: Visual prosthesis; Device
Lead sponsor: University of California, Santa Barbara; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Rheumatoid Arthritis
Interventions: Indocyanine Green, MultiSpectral Imaging System; Drug · Device
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 89 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Sentinel Lymph Node
Interventions: ICG Intervention, Near Infrared Imaging; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer
Interventions: NIR imaging system; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Wound Heal
Interventions: Near Infrared Spectroscopy; Diagnostic Test
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Lung Cancer, Lung Nodule, Non Small Cell Lung Cancer
Interventions: SGM-101, Near infrared camera imaging system; Drug · Device
Lead sponsor: Sunil Singhal; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cholecystitis
Interventions: Injection of indocyanine green (ICG), Near Infrared Cholangiography Fluorescence (NIRF-C); Drug · Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Primary Hyperparathyroidism
Interventions: NIRAF-camera; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Squamous Cell Carcinoma of the Head and Neck, Carcinoma of the Head and Neck
Interventions: Panitumumab-IRDye800, 89-Zirconium (Zr-89) Panitumumab, Pinpoint IR IR9000 fluorescence imaging system (FIS), SPY-PHI IR9000 fluorescence imaging system (FIS), Explorer Air camera, PDE-NEO II camera, FIS-00 fluorescence imaging system (FIS), Da Vinci Firefly Imaging System, IGP-ELVIS-v4 Macroscopic Specimen Imager, Vevo 3100 LAZR-X, Pearl Triology Imaging System, Odyssey CLx Imaging System, Leica fluorescence microscope; Drug · Device
Lead sponsor: Andrei Iagaru; Other
Eligibility: 19 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Ovarian Cancer
Interventions: OTL38, Near infrared camera imaging system, Laparotomy; Drug · Device · Procedure
Lead sponsor: On Target Laboratories, LLC; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: Orange, California • Tampa, Florida • Rochester, Minnesota + 1 more

Search by objective public record fields.

Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions

The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy

Longitudinal Spatial Frequency Domain Imaging Study

Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

Nurse PIV Insertion Success With and Without Assistive Devices in Patients 0-12 Months of Age

Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study

ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting

A Study of Effects of Age and Hyperkyphosis on Spine Motion and Loading

Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging

Pilot Study to Assess the Use of Spy Elite for Assessment of Amputation Healing

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

AI-Powered Artificial Vision for Visual Prostheses

Near InfraRed Fluorescence Using Indocyanine Green and Magnetic Resonance Lymphography of Lymphatic Transport

Bronchial NIR Image-guided Resection

Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer

Accuracy of TCOM vs NIRS in Predicting Wound Outcomes in Patients Treated With or Without Revascularization

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy

NIRAF-camera Versus Conventional Surgery in Preoperative Imaging Negative Primary Hyperparathyroidism

Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer